Omnicare, Inc.  

(Public, NYSE:OCR)   Watch this stock  
Find more results for OCR
94.29
+0.09 (0.10%)
Jul 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 94.14 - 94.42
52 week 59.85 - 96.54
Open 94.33
Vol / Avg. 1.76M/3.58M
Mkt cap 9.13B
P/E 50.03
Div/yield 0.22/0.93
EPS 1.88
Shares 96.88M
Beta 1.26
Inst. own 103%
Jun 1, 2015
Omnicare Inc Annual Shareholders Meeting
May 12, 2015
Omnicare Inc at Bank of America Merrill Lynch Health Care Conference - Webcast
Apr 29, 2015
Q1 2015 Omnicare Inc Earnings Release
Apr 29, 2015
Q1 2015 Omnicare Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.66% 2.87%
Operating margin 9.16% 6.66%
EBITD margin - 10.62%
Return on average assets 5.05% 2.88%
Return on average equity 12.14% 6.91%
Employees 11,726 -
CDP Score - -

Address

201 E 4th St
CINCINNATI, OH 45202-4248
United States - Map
+1-513-7192600 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.

Officers and directors

Nitin Sahney President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Robert O. Kraft Chief Financial Officer, Senior Vice President
Age: 44
Bio & Compensation  - Reuters
Kirsten Marriner Chief Human Resources Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Alexander M. Kayne Senior Vice President, General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters
David Hileman Senior Vice President-Commercial Operations
Age: 51
Bio & Compensation  - Reuters
Amit Jain Senior Vice President-Operations and Sales
Age: 42
Bio & Compensation  - Reuters
James D. Shelton Independent Non-Executive Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
John L. Bernbach Independent Director
Age: 71
Bio & Compensation  - Reuters
James G. Carlson Independent Director
Age: 62
Bio & Compensation  - Reuters
Mark A. Emmert Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters